"MF by the look of the chart 5 cents can't be far away...very low MC for the technology..."
Pigofsteel I think we will see 5 by Christmas easily. Check the link I posted the other day on market caps of start up stem cell companies. Most are 100m plus.
For the technology this company has in the stable (WARF) and the allogenic repeatable low risk profile of MCA's the fuse will be lit on this one for years into the future on trials etc and funding proving inflection points for the company.
Just because trials are not at stage 2/3 does not mean that the company has a very good shot at blue sky and will be rerated accordingly.
Bluebird bio - 600m cap
ECQ Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
